Aller au contenu principal
Profil bibliographique

Salman J. Khan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

59Publications signalées
198Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Chronic Lymphocytic Leukemia ResearchBlood groups and transfusionTuberculosis Research and EpidemiologyLymphoma Diagnosis and TreatmentCAR-T cell therapy research

Les publications récentes

2026 article OpenAlex

Efficacy and safety of CD3×CD20 bispecific antibodies in Richter transformation: A systematic review of prospective trials and comparative analysis.

Salman J. Khan, Hamza Usman, Seemab Sheikh, Kelvin Rojas et autres

e19095 Background: Richter transformation (RT), the progression of chronic lymphocytic leukemia to aggressive diffuse large B-cell lymphoma, carries poor outcomes. Chemoimmunotherapy (CIT), including R-CHOP, remains commonly used in the frontline setting, while CD19-directed CAR T-cell therapy is used mainly in relapsed/refractory (R/R) …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2026 article OpenAlex

Progressive Pulmonary Lesions and Cervical Lymphadenopathy Revealing Large B-cell Lymphoma: A Rare Case Report

Muhammad Rizwan Tariq, Blessing T Ojinna, Efrah Ashraf, Arshia Ahmed et autres

Primary pulmonary and thyroid diffuse large B-cell lymphoma (DLBCL) is an exceptionally rare extranodal manifestation of non-Hodgkin lymphoma and often presents with nonspecific clinical and radiographic features, leading to significant diagnostic challenges. We report a case of a 70-year-old woman with extensive …

pk, us (code pays fourni par la source)

0 citations Cureus
2026 article OpenAlex

Advanced cardiac imaging in cardiac sarcoidosis: current evidence and future directions

Awais Aslam, Wahab Jahangir Khan, Syed H. Haq, Ifrah Nadeem et autres

Cardiac sarcoidosis (CS) is a rare and complex disease that requires a multidisciplinary approach for diagnosis and treatment. The diagnosis of CS can be confirmed by histological examination of non-caseating granulomas in cardiac or extracardiac tissue, along with supportive clinical and imaging …

us (code pays fourni par la source)

2 citations Heart
Accès ouvert 2025 conference-abstract OpenAlex

Outcomes with repeat CAR-t cell therapy: A systematic review and meta-analysis

Hafiz Muhammad Asif Javed, Fatima Sial, Farooq Ashraf, Aman Ullah et autres

Abstract Introduction: Chimeric Antigen Receptor (CAR) T-cell therapy has transformed the treatment of relapsed or refractory B-cell malignancies. Repeat CAR T-cell therapy (CART2) is a potential approach for patients with suboptimal response to initial treatment or who relapse. Here we report outcomes …

us, pk (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 conference-abstract OpenAlex

Real-world analysis of infection timing and burden in multiple myeloma patients treated with teclistamab

Divya Chukkalore, Phyu Thin Naing, Kelvin Zheng, Richa Thakur et autres

Abstract Background Teclistamab, a BCMA x CD3 bispecific antibody, is a highly effective novel therapeutic option for patients with relapsed/refractory multiple myeloma (RRMM). Clinical trials like MajesTEC-1 show impressive efficacy but also high early infection rates, likely due to immune disruption from …

us, Afrique du Sud (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 conference-abstract OpenAlex

Eculizumab for hyperhemolysis syndrome in sickle cell disease: A systematic review and meta-analysis

Moazzam Shahzad, Muhammad Shaheer Mannan, Hafiz Muhammad Asif Javed, Farooq Ashraf et autres

Abstract Background Hyperhemolysis syndrome (HHS) is a rare, potentially fatal transfusion complication seen in patients with sickle cell disease (SCD), characterized by the destruction of both donor and recipient red blood cells, leading to a paradoxical drop in hemoglobin. Eculizumab, a monoclonal …

us, pk (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 article OpenAlex

Association of antiphospholipid syndrome with infective endocarditis and sepsis induced by Staphylococcus aureus: A U.S. nationwide inpatient sample analysis

Bahy Abofrekha, Jessica Schwartz, Chloé Lahoud, Ahmad Mustafa et autres

Background Antiphospholipid syndrome (APS) predisposes patients to thrombosis and cardiac valve lesions such as Libman-Sacks endocarditis. These vegetations are sterile yet can provide a nidus for infection; the risk of infective endocarditis (IE) and other serious infections in APS patients remains poorly …

us (code pays fourni par la source)

0 citations Lupus
Accès ouvert 2025 article OpenAlex

A Case of Pericarditis With Pericardial Effusion Due to Lyme Disease

Osamede Agho, Sara Tariq, Arshia Ahmed, Salman J. Khan et autres

Acute pericarditis with pericardial effusion caused by Lyme disease is very rare and requires excluding other more common possible causes of acute pericarditis. Common causes of acute pericarditis include viral and bacterial infections, connective tissue disorders such as rheumatoid arthritis, systemic lupus …

us, Nigéria (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2025 conference-abstract OpenAlex

Induction chemotherapy for locally advanced sinonasal carcinoma: A systematic review and meta-analysis.

Atif Saleem Butt, Muhammad Fareed Khalid, Ammad Naeem, Salman J. Khan et autres

e18160 Background: Induction chemotherapy (IC) has emerged as a promising approach in the management of locally advanced sinonasal carcinoma. Recent studies have demonstrated that IC can lead to significant tumor reduction, facilitating subsequent definitive treatments such as chemoradiotherapy (CRT) or surgery, and …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.